Proteaseresistente Urokinase-Zusammensetzung, deren Herstellung und Verwendung.

摘要

Novel single-chain protease resistant urokinase derivatives are provided. In particular, derivatives are provided wherein the Lys135Lys136 and Arg156 to Lys158 sites are rendered less susceptible to proteolytic cleavage are provided by occluding the sites or by covalently modifying them. Preferred covalent modifications are amino acid sequence variants at the sites where proteolysis of urokinase occurs. These are optimally produced by synthesis of single-chain urokinase mutants in recombinant cell culture. The novel urokinase derivatives herein offer the advantage of avoiding the generation of substantial two-chain urokinase, either in vivo or during recombinant cell culture. However, the derivatives continue function to activate plasminogen in initiating blood clot lysis.